FDA to Review Uridine Triacetate as Antidote to Serious 5-FU Toxicity
September 10th 2015The FDA will review a new drug application for the oral agent uridine triacetate as a treatment for patients at risk of serious toxicity following an overdose of 5-fluorouracil (5-FU) or are exhibiting symptoms of serious toxicity within 96 hours of 5-FU administration.
Most Young Lung Cancer Patients Have Actionable Mutations
September 9th 2015A preliminary analysis of an ongoing study shows that most patients diagnosed with lung cancer before age 40 had an increased chance for a targeted genomic alteration, knowledge of which could lead to more effective, targeted treatment.
Endometrial Cancer on the Rise and Impacts Black Women the Most
August 21st 2015Rates of endometrial cancer continue to increase among all racial and ethnic groups, but they're rising faster among non-Hispanic black women who also have poorer outcomes when compared with their white, non-Hispanic counterparts.